Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article CaaMTech Teams Up With University of Wyoming to Study Psychedelics as Treatments for Addiction

CaaMTech Teams Up With University of Wyoming to Study Psychedelics as Treatments for Addiction

  • Post published:November 16, 2021
  • Post category:Press Release
Read more about the article CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development

CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development

  • Post published:September 8, 2021
  • Post category:Press Release
Read more about the article Patent Combining Psychedelics with Cannabinoids Allowed by USPTO

Patent Combining Psychedelics with Cannabinoids Allowed by USPTO

  • Post published:February 10, 2021
  • Post category:Press Release
Read more about the article Andrew Chadeayne, Founder and CEO of CaaMTech

Andrew Chadeayne, Founder and CEO of CaaMTech

  • Post published:December 10, 2020
  • Post category:Interview
Read more about the article CaaMTech Expands Successful Next-Gen Drug Research Collaboration with UMass Dartmouth

CaaMTech Expands Successful Next-Gen Drug Research Collaboration with UMass Dartmouth

  • Post published:December 9, 2020
  • Post category:Press Release
Read more about the article CaaMTech Collaborates With the Leibniz Institute for Natural Product Research to Investigate Psychedelic Mushrooms

CaaMTech Collaborates With the Leibniz Institute for Natural Product Research to Investigate Psychedelic Mushrooms

  • Post published:December 1, 2020
  • Post category:Press Release
Read more about the article CaaMTech Researchers Synthesize and Structurally Characterize Deprocin Hydrochloride

CaaMTech Researchers Synthesize and Structurally Characterize Deprocin Hydrochloride

  • Post published:November 30, 2020
  • Post category:Press Release
Read more about the article CaaMTech Synthesizes Novel Tryptamine Prophoria™, Amphoria™

CaaMTech Synthesizes Novel Tryptamine Prophoria™, Amphoria™

  • Post published:July 7, 2020
  • Post category:Press Release
Read more about the article Interview with CaaMTech

Interview with CaaMTech

  • Post published:April 28, 2020
  • Post category:Interview

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More